Study Name: An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N Compared With Plasma for Rapid R
18 locations found
- Study Site
Location: Birmingham, Alabama 35248
- Study Site
Location: Newark, Delaware 19718
- Study Site
Location: Tampa, Florida 33606
- Study site
Location: Lexington, Kentucky 40536
- Study Site
Location: Boston, Massachusetts 02114
- Study Site
Location: Duluth, Minnesota 55805
- Study Site
Location: Minneapolis, Minnesota 55415
- Study Site
Location: Albuquerque, New Mexico 87131
- Study Site
Location: Rochester, New York 14642
- Study Site
Location: Winston-Salem, North Carolina 27157
- Study Site
Location: Philadelphia, Pennsylvania 19107
- Study Site
Location: West Reading, Pennsylvania 19611
- Study Site
Location: Wilkes Barre, Pennsylvania 18711
- Study Site
Location: Memphis, Tennessee 38163
- Study Site
Location: Austin, Texas 78701
- Study site
Location: Bryan, Texas 77802
- Study Site
Location: El Paso, Texas 79905
- Study Site
Location: Houston, Texas 77030
|